Your browser doesn't support javascript.
loading
Preclinical and clinical safety studies on DNA vaccines.
Schalk, Johanna A C; Mooi, Frits R; Berbers, Guy A M; van Aerts, Leon A G J M; Ovelgönne, Hans; Kimman, Tjeerd G.
Afiliação
  • Schalk JA; Centre for Biological Medicines and Medical Technology, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. marjolijn.schalk@rivm.nl
Hum Vaccin ; 2(2): 45-53, 2006.
Article em En | MEDLINE | ID: mdl-17012886
ABSTRACT
DNA vaccines are based on the transfer of genetic material, encoding an antigen, to the cells of the vaccine recipient. Despite high expectations of DNA vaccines as a result of promising preclinical data their clinical utility remains unproven. However, much data is gathered in preclinical and clinical studies about the safety of DNA vaccines. Here we review current knowledge about the safety of DNA vaccines. Safety concerns of DNA vaccines relate to genetic, immunologic, toxic, and environmental effects. In this review we provide an overview of findings related to the safety of DNA vaccines, obtained so far. We conclude that the potential risks of DNA vaccines are minimal. However, their safety issues may differ case-by-case, and they should be treated accordingly.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas de DNA Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2006 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas de DNA Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2006 Tipo de documento: Article